PATENT CLAIM ANALYSIS

Application Number: 15769295
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "243000"]

Abstract:
The present invention provides a compound which has a cholinergic muscarinic M1 receptor positive allosteric modulator activity and may be useful as a medicament such as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, Lewy body dementia and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. In the formula (I), each symbol is as described in the attached specification.

Claim (Index 14):
A method of cholinergic muscarinic M1 receptor positive allosteric modulation in a mammal, which comprises administering an effective amount of the compound according to  claim 1  or a salt thereof to the mammal.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 91.0
- Lexical Diversity: 1.47619
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15735418', '15830634', '16083295', '15306012', '15318552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8115924301196602
- 35 USC 102 Novelty (BERT): 0.5793616401255332
- Combined Prediction Score: 0.7883693511202475
- Mean Citation Score: 438.68419000000006
- Max Citation Score: 456.96445
- Similarity Product: 429.4568625614673

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test